美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Latigo Biotherapeutics Inc

22.15

+0.61002.83%

盤後：22.150.00000.00%16:43 EDT

成交量：17.87萬

成交額：393.01萬

市值：14.69億

市盈率：-13.22

高：23.22

開：21.76

低：21.50

收：21.54

52周最高：25.93

52周最低：17.22

股本：6,629.93萬

流通股本：2,212.13萬

量比：0.78

換手率：0.81%

股息：- -

股息率：- -

每股收益(TTM):-1.6760

每股收益(LYR):-129.2325

淨資產收益率：--

總資產收益率：--

市淨率：-5.32

市盈率(LYR):-0.17

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Latigo Biotherapeutics Inc

交易所：

NASDAQ

成立時間：

2018

員工人數：

66

公司地址：

1300 Rancho Conejo Boulevard,Suite 305,Thousand Oaks,California,United States

官網：

http://www.latigobio.com

郵編：

91320

電話：

傳真：

- -

簡介：

Latigo Biotherapeutics, Inc.於2018年11月在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司，致力於開發創新的非阿片類鎮痛藥物，旨在抑制疼痛傳播而不會產生成癮風險。其管道主要集中在Nav1.8抑製劑，初步開發努力針對肌肉骨骼疼痛。該公司還計劃探索涉及疼痛傳遞的其他離子通道靶點，以建立最廣泛的疼痛療法管道之一。

董事

名稱

職位

Nima Farzan

Chief Executive Officer and Director and President

Timothy P. Walbert

Chairman of the Board and Director

Beth Seidenberg

Director

Deborah Palestrant

Director

James B. Tananbaum

Director

Kevin Raidy

Director

Sara Bonstein

Director

Todd N. Smith

Director

股東

名稱

職位

Nima Farzan

Chief Executive Officer and Director and President

Neha Krishnamohan

Chief Business Officer and Chief Financial Officer

Neil Singla

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/LTGO/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LTGO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","market":"US","secType":"STK","nameCN":"Latigo Biotherapeutics Inc","latestPrice":22.15,"timestamp":1789156800000,"preClose":21.54,"halted":0,"volume":178712,"hourTrading":{"tag":"盘后","latestPrice":22.15,"preClose":22.15,"latestTime":"16:43 EDT","volume":383,"amount":8483.45,"timestamp":1789159399292,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.028319405756731638,"floatShares":22121291,"shares":66299347,"eps":-1.676,"marketStatus":"休市中","change":0.61,"latestTime":"09-11 16:00:00 EDT","open":21.76,"high":23.22,"low":21.502,"amount":3930145.84156,"amplitude":0.079759,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.676,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":21.54,"preHourTrading":{"tag":"盘前","latestPrice":22.7,"preClose":21.54,"latestTime":"08:29 EDT","volume":8,"amount":178.84,"timestamp":1789129766708,"change":1.16,"changeRate":0.053853,"amplitude":0.079387},"postHourTrading":{"tag":"盘后","latestPrice":22.15,"preClose":22.15,"latestTime":"16:43 EDT","volume":383,"amount":8483.45,"timestamp":1789159399292,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7759069073714153},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","floatShares":22121291,"roa":"--","roe":"--","lyrEps":-129.23255,"volumeRatio":0.7759069073714153,"shares":66299347,"dividePrice":0,"high":23.22,"amplitude":0.079759,"preClose":21.54,"low":21.502,"week52Low":17.2201,"pbRate":"-5.32","week52High":25.93,"institutionHeld":0,"latestPrice":22.15,"eps":-1.676,"divideRate":0,"volume":178712,"delay":0,"ttmEps":-1.676,"open":21.76,"prevYearClose":18,"prevWeekClose":23.04,"prevMonthClose":22.02,"prevQuarterClose":18,"fiveDayClose":22.48,"twentyDayClose":20.06,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTGO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTGO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTGO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1789099200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTGO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTGO","date":"2026-09-11","current":-13.21599,"percent":0.25,"low":-14.220252,"twenty":-13.626145,"median":-12.513822,"eighty":-11.012163,"high":-10.257227,"avg":-12.24787,"sd":1.216522,"marketCap":1428087934},"quantilePoints":[{"date":"2026-08-07","current":-10.257227,"twenty":-10.257227,"median":-10.257227,"eighty":-10.257227,"marketCap":1140357438},{"date":"2026-08-14","current":-11.41033,"twenty":-11.020695,"median":-10.545739,"eighty":-10.380784,"marketCap":1268554881},{"date":"2026-08-21","current":-12.172536,"twenty":-11.41033,"median":-11.020695,"eighty":-10.534363,"marketCap":1353293842},{"date":"2026-08-28","current":-14.220252,"twenty":-12.724282,"median":-11.393266,"eighty":-10.557115,"marketCap":1580950750},{"date":"2026-09-04","current":-12.786851,"twenty":-12.786851,"median":-12.172536,"eighty":-10.978035,"marketCap":1421590914},{"date":"2026-09-11","current":-12.849682,"twenty":-13.626145,"median":-12.513822,"eighty":-11.012163,"marketCap":1428087934}],"updateTime":1789325568973},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":672821642,"yearFounded":2018,"employeeNum":66,"address":"1300 Rancho Conejo Boulevard,Suite 305,Thousand Oaks,California,United States","zipCode":"91320","officePhone":"805 716 2927","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.latigobio.com","stockEarnings":[{"period":"1week","weight":-0.0386},{"period":"1month","weight":0.1432},{"period":"3month","weight":0.2306},{"period":"ytd","weight":0.2306}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Latigo Biotherapeutics, Inc.於2018年11月在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司，致力於開發創新的非阿片類鎮痛藥物，旨在抑制疼痛傳播而不會產生成癮風險。其管道主要集中在Nav1.8抑製劑，初步開發努力針對肌肉骨骼疼痛。該公司還計劃探索涉及疼痛傳遞的其他離子通道靶點，以建立最廣泛的疼痛療法管道之一。","exchange":"NASDAQ","name":"Latigo Biotherapeutics Inc","nameEN":"Latigo Biotherapeutics Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LTGO\",market:\"US\",,,undefined,":{"directors":[{"name":"Nima Farzan","position":"Chief Executive Officer and Director and President"},{"name":"Timothy P. Walbert","position":"Chairman of the Board and Director"},{"name":"Beth Seidenberg","position":"Director"},{"name":"Deborah Palestrant","position":"Director"},{"name":"James B. Tananbaum","position":"Director"},{"name":"Kevin Raidy","position":"Director"},{"name":"Sara Bonstein","position":"Director"},{"name":"Todd N. Smith","position":"Director"}],"executives":[{"name":"Nima Farzan","position":"Chief Executive Officer and Director and President"},{"name":"Neha Krishnamohan","position":"Chief Business Officer and Chief Financial Officer"},{"name":"Neil Singla","position":"Chief Medical Officer"}]}}}